<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>According to tradition, every year, at the Congress of the European Society of Cardiology new clinical guidelines, usefull for our daily pratice, are launched. This year a new guideline for the management of non-ST-segment elevation myocardial infarction (NSTEMI) was presented. Substantial resources had been invested to sustain the research efforts in order to improve the diagnosis and therapeutic tools for this disease.</p>
<p>In this article we present the main differences between this guideline and the previous one, regarding the utility of the cardiac biomarkers, diagnosis and risk stratification algorithms, and last, but not least, medical and invasive treatment tools.</p>
</abstract>

According to tradition, every year, at the Congress of the European Society of Cardiology new clinical guidelines, usefull for our daily pratice, are launched. This year a new guideline for the management of non-ST-segment elevation myocardial infarction (NSTEMI) was presented. Substantial resources had been invested to sustain the research efforts in order to improve the diagnosis and therapeutic tools for this disease.
In this article we present the main differences between this guideline and the previous one, regarding the utility of the cardiac biomarkers, diagnosis and risk stratification algorithms, and last, but not least, medical and invasive treatment tools.

NSTEMI Guideline During the Covid-19 Pandemia, the Missing Piece What’s New in the 2020 ESC Practice Guidelines?

“Carol Davila” University of Medicine and Pharmacy

Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

According to tradition, every year, at the Congress of the European Society of Cardiology new clinical guidelines, usefull for our daily pratice, are launched....

NSTEMI Guideline During the Covid-19 Pandemia, the Missing Piece What’s New in the 2020 ESC Practice Guidelines?

Online veröffentlicht: 27. Juli 2021

Seitenbereich: 51 - 56

DOI: https://doi.org/10.2478/inmed-2021-0166

Schlüsselwörter
NSTEMI, cardiac biomarkers, diagnosis, risk, treatment

© 2021 Mădălina Badea et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

NSTEMI Guideline During the Covid-19 Pandemia, the Missing Piece What’s New in the 2020 ESC Practice Guidelines?

Online veröffentlicht: 27. Juli 2021

Seitenbereich: 51 - 56

DOI: https://doi.org/10.2478/inmed-2021-0166

SchlüsselwörterNSTEMI, cardiac biomarkers, diagnosis, risk, treatment

© 2021 Mădălina Badea et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
NSTEMI, cardiac biomarkers, diagnosis, risk, treatment